Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue: +38.3%
EPS: −294.7%
Free cash flow: +5.09%
Total debt: +40.8%

Quarter to June 2026, against a year earlier

25.29 1.23 +5.11%

Follow HIMS

Alert me

Market cap: $5.6B
P/E: 0.0×
Fwd P/E: −49.4×
Dividend yield: —
F-score: 4/9
Altman Z: 4.10
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Hims & Hers Health, Inc. 8-K filed Oct 7, 2026

Period ended Oct 7, 2026 · Filed Oct 7, 2026 · accepted 4:13 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers

Red flags

Officer departure Oct 7, 2026
Hims & Hers Health, Inc. reported the departure of an officer or director

8-K filed Oct 7, 2026 · The filing · sec.gov